Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The "Pharmacokinetics Services Market Size, Share & Trends Analysis Report By Drug Type (Small Molecules), By Application (SMEs) By End-use (Biotechnology & Pharmaceutical Companies) By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global pharmacokinetics services market size is expected to reach USD 1, 762.4 million by 2030, registering a CAGR of 7.5% from 2023 to 2030
Rising adoption of pharmacokinetic and toxicology studies for determination of several parameters such as no-observed-effect levels (NOEL), human equivalent doses (HED) levels, and pharmacokinetic/pharmacodynamic (PK/PD) drivers are expected to fuel market growth. 
Thorough understanding of the pharmacokinetic profile of a potential drug candidate plays a major role in the success of a drug discovery program. In addition to this, regulatory bodies have played a major role in the progress of this market through establishing defined guidelines for conducting PK studies. There are a substantial number of CROs engaged in conducting PK studies in accordance with relevant EMEA, ICH, FDA, GCP, and other regulatory guidelines.
Growing concern for effective implementation of PK services in the drug development process is anticipated to drive investments in this sector. Several conferences and certification courses are being conducted across the world to increase the understanding of various paradigms associated with pharmacokinetics application in clinical and preclinical drug development.
Pharmacokinetics Services Market Report Highlights
- Based on drug type, Small molecule dominated the market with a revenue share of 76.7% in 2022 and is expected to maintain its lead during the forecast period fueled by high service penetration and growing popularity of generics
- PK analysis for large molecules are expected to grow significantly during the forecast period, driven by presence of significant number of biologics and biosimilars in the clinical development phase
- Presence of a large number of biopharmaceutical and pharmaceutical manufacturing entities in U.S. has resulted in North America accounting for the largest share in 2022
- Asia Pacific is estimated to expand at the fastest CAGR of 9.2% over the forecast period thanks to constant economic growth in several countries, which has attracted significant attention from global CROs and resulted in business expansions
- Pharmaceutical Product Development, LLC; Charles River Laboratories International, Inc.; PAREXEL International Corporation; and Eurofins Scientific, Inc. are some of the key service providers
- These CROs are undertaking various initiatives in order to capitalize on new market avenues and enhance their share in the future market.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 110 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $981.8 Million |
| Forecasted Market Value (USD) by 2030 | $1762.4 Million |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
Company Profiles
- Evotec AG
- Certara, L.P.
- Pacific BioLabs
- GVK Biosciences Private Limited
- Shanghai Medicilon Inc.
- Pharmaceutical Product Development, LLC
- Charles River Laboratories International, Inc.
- PAREXEL International Corporation
- Eurofins Scientific, Inc.
- Frontage Labs
- SGS SA
- LGC Limited
- Creative Bioarray
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Drug Type outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Pharmacokinetic Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Pharmacokinetic Services Market Analysis Tools
3.4.1. Industry Analysis - Porter's
3.4.2. PESTEL Analysis
Chapter 4. Pharmacokinetic Services Market: Drug Type Estimates & Trend Analysis
4.1. Pharmacokinetic Services Market, Key Takeaways
4.2. Pharmacokinetic Services Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Small Molecule
4.3.1. Small molecule market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Large Molecules (Biopharmaceuticals)
Chapter 5. Pharmacokinetic Services Market: Application Estimates & Trend Analysis
5.1. Pharmacokinetic Services Market, Key Takeaways
5.2. Pharmacokinetic Services Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Small and Medium Enterprise
5.3.1. Small and medium enterprise market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Large Enterprise
Chapter 6. Pharmacokinetic Services Market: End Use Estimates & Trend Analysis
6.1. Pharmacokinetic Services Market, Key Takeaways
6.2. Pharmacokinetic Services Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Biotechnology & Pharmaceutical Companies
6.3.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Academic & Government Research Institutes
Chapter 7. Pharmacokinetic Services Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Pharmacokinetic Services Market by Region: Key Takeaways
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
For more information about this report visit https://www.researchandmarkets.com/r/9ka7it
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
